The impact of vedolizumab and ustekinumab on arthropathy and arthralgia in IBD patients: a real-life multicentric cohort study

被引：3

作者：

Truyens, M. ^{[1
,2
,3
,4
]}

De Galan, C. ^{[1
,3
,4
]}

Peeters, H. ^{[5
]}

Mesonero Gismero, F. ^{[6
]}

Elorza, A. ^{[7
]}

Torres, P. ^{[8
]}

Vandermeulen, L. ^{[9
]}

Amezaga, A. Jauregui ^{[10
]}

Ferreiro-Iglesias, R. ^{[11
]}

Holvoet, T. ^{[12
]}

Zabana, Y. ^{[13
,14
]}

Reverter, L. Peries ^{[15
]}

Geldof, J. ^{[2
]}

Varkas, G. ^{[4
,16
]}

De Vos, M. ^{[1
,2
,3
]}

Lobaton, T. ^{[1
,2
]}

机构：

[1] Univ Ghent, Dept Internal Med & Pediat, Ghent, Belgium

[2] Univ Hosp Ghent, Dept Gastroenterol, Ghent, Belgium

[3] Univ Ghent, Ghent Gut Inflammat Grp GGIG, Ghent, Belgium

[4] Univ Ghent, VIB Ctr Inflammat Res IRC, Ghent, Belgium

[5] AZ Sint Lucas, Dept Gastroenterol, Ghent, Belgium

[6] Hosp Ramon & Cajal, Dept Gastroenterol, Madrid, Spain

[7] Hosp Galdakao, Dept Gastroenterol, Bilbao, Spain

[8] Hosp Badalona Germans Trias & Pujol, Dept Gastroenterol, Barcelona, Spain

[9] Vrije Univ Brussel VUB, Univ Ziekenhuis Brussel, Dept Gastroenterol, Brussels, Belgium

[10] Univ Hosp Antwerp, Dept Gastroenterol, Antwerp, Belgium

[11] Hosp Clin Univ Santiago, Dept Gastroenterol, Santiago De Compostela, Spain

[12] AZ Nikolaas, Dept Gastroenterol, St Niklaas, Belgium

[13] Hosp Univ Mutua Terrassa, Dept Gastroenterol, Barcelona, Spain

[14] Hosp Univ Mutua Terrassa, CIBERehd, Barcelona, Spain

[15] Hosp Univ Girona, Dept Gastroenterol, Girona, Spain

[16] Univ Hosp Ghent, Dept Rheumatol, Ghent, Belgium

来源：

JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷

关键词：

D O I：

10.1093/ecco-jcc/jjab076.391

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P266

引用

页码：S302 / S302

页数：1

共 50 条

[1] Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study
Holvoet, Tom
Truyens, Marie
De Galan, Cara
Peeters, Harald
Gismero, Francisco Mesonero
Elorza, Ainara
Torres, Paola
Vandermeulen, Liv
Jauregui-Amezaga, Aranzazu
Ferreiro-Iglesias, Rocio
Zabana, Yamile
Reverter, Laia Peries
Geldof, Jeroen
Lobaton, Triana
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
[2] The Impact of Vedolizumab and Ustekinumab on Articular Extra-Intestinal Manifestations in Inflammatory Bowel Disease Patients: A Real-Life Multicentre Cohort Study
De Galan, Cara
Truyens, Marie
Peeters, Harald
Gismero, Francisco Mesonero
Elorza, Ainara
Torres, Paola
Vandermeulen, Liv
Amezaga, Aranzazu Jauregui
Ferreiro-Iglesias, Rocio
Holvoet, Tom
Zabana, Yamile
Reverter, Laia Peries
Gonzales, Gerard Bryan
Geldof, Jeroen
Varkas, Gaelle
De Vos, Martine
Lobaton, Triana
JOURNAL OF CROHNS & COLITIS, 2022, 16 (11): : 1676 - 1686
[3] A multicentric study on real-life impact of nivolumab in patients with hepatocellular carcinoma
Gomes da Fonseca, Leonardo
Minguez, Beatriz
Perello, Christie
de la Torre, Manuel
Marquez, Laura
Guerrero Garcia, Antonio
Torner Simo, Maria
Pons, Monica
Calleja Panero, Jose Luis
Sangro, Bruno
Matilla, Ana M.
Luis Lledo, Jose
Varela, Maria
Rimola, Jordi
Bruix, Jordi
Reig, Maria
JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E88 - E88
[4] EFFICACY OF USTEKINUMAB IN A COHORT OF PATIENTS AFFECTED BY PSORIATIC ARTHRITIS IN REAL-LIFE
Notario Ferreira, I.
Ferrer Gonzalez, M.
Morales Garrido, P.
Anon Onate, I.
Perez Albaladejo, L.
Caro Hernandez, C.
Gonzalez Utrilla, A.
Raya Alvarez, E.
Caliz Caliz, R.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1321 - 1321
[5] COMPARATIVE OBJECTIVE EFFECTIVENESS OF VEDOLIZUMAB AND USTEKINUMAB IN A REAL-LIFE COHORT OF ACTIVE CROHN'S DISEASE PATIENTS FAILURE TO TNF INHIBITORS
Onali, S.
Pugliese, D.
Caprioli, F. A.
Orlando, A.
Biancone, L.
Nardone, O. M.
Imperatore, N.
Fiorino, G.
Cappello, M.
Viola, A.
Principi, M. B.
Bezzio, C.
Aratari, A.
Carparelli, S.
Mancuso, F.
Grossi, L.
Bodini, G.
Ribaldone, D.
Mocci, G.
Favale, A.
Grova, M.
Scucchi, L.
Segato, S.
Fries, W.
Castiglione, F.
Armuzzi, A.
Fantini, M. C.
DIGESTIVE AND LIVER DISEASE, 2022, 54 : S140 - S141
[6] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
Onali, S.
Pugliese, D.
Caprioli, F. A.
Orlando, A.
Biancone, L.
Nardone, O. M.
Imperatore, N.
Fiorino, G.
Cappello, M.
Viola, A.
Principi, M. B.
Bezzio, C.
Aratari, A.
Carparelli, S.
Mazzuoli, S.
Manguso, F.
Grossi, L.
Bodini, G.
Ribaldone, D.
Mocci, G.
Minerba, L.
Favale, A.
Grova, M.
Scucchi, L.
Segato, S.
Fries, W.
Castiglione, F.
Armuzzi, A.
Fantini, M. C.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
[7] Comparative objective effectiveness of vedolizumab and ustekinumab in a real-life cohort of active Crohn's disease patients failure to TNF inhibitors
Onali, S.
Pugliese, D.
Caprioli, F. A.
Orlando, A.
Biancone, L.
Nardone, O. M.
Imperatore, N.
Fiorino, G.
Cappello, M.
Viola, A.
Principi, M. B.
Bezzio, C.
Aratari, A.
Carparelli, S.
Mazzuoli, S.
Manguso, F.
Grossi, L.
Bodini, G.
Ribaldone, D.
Mocci, G.
Minerba, L.
Favale, A.
Grova, M.
Scucchi, L.
Segato, S.
Fries, W.
Castiglione, F.
Armuzzi, A.
Fantini, M. C.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I542 - I543
[8] Pharmacokinetics and clinical evaluation of vedolizumab based on real-life routine monitoring data in IBD patients
Markovic, S.
Kralj, D.
Odanovic, O.
Homsek, A.
Kalaba, A.
Svorcan, P.
Vucicevic, K.
JOURNAL OF CROHNS & COLITIS, 2023, 17 : 925 - 925
[9] Vedolizumab vs. ustekinumab for Crohn's disease: comparative effectiveness in a real-life observational cohort study (ICC case series)
Biemans, V.
van der Woude, C.
van der Meulen-de Jong, A.
Dijkstra, G.
de Boer, N.
Oldenburg, B.
Ponsioen, C.
de Vries, A.
Wintjens, D.
Hoentjen, F.
Pierik, M.
JOURNAL OF CROHNS & COLITIS, 2018, 12 : S66 - S67
[10] REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: A MULTICENTRIC REAL-LIFE STUDY
Bruno, Francesco
Pellerino, Alessia
Pronello, Edoardo
Palmiero, Rosa
Polo, Valentina
Vitaliani, Roberta
Trincia, Elena
Interno, Valeria
Porta, Camillo
Soffietti, Riccardo
Ruda, Roberta
NEURO-ONCOLOGY, 2022, 24 : 76 - 76

← 1 2 3 4 5 →